Empirical Trials in Treatment of Gastroesophageal Reflux Disease
Author:
- 15 June 2000
- journal article
- review article
- Published by S. Karger AG in Digestive Diseases
- Vol. 18 (1) , 20-26
Abstract
The assortment of diagnostic tests that are currently available for detecting gastroesophageal reflux disease (GERD) are invasive, costly and not readily available to community-based physicians. In contrast, a short course of high-dose proton pump inhibitor (PPI) as an empirical trial is an attractive alternative. This simple diagnostic test has been demonstrated to be accurate and cost-effective in patients with symptoms suggestive of GERD and those with noncardiac chest pain. Early studies in patients with extraesophageal manifestations of GERD have yielded promising results. Cost assessment of the PPI empirical trial revealed significant cost savings, mainly due to a marked decrease in utilization of invasive diagnostic tests. Thus the PPI empirical trial should be considered as the initial diagnostic step in patients with the disease spectrum of GERD.Keywords
This publication has 5 references indexed in Scilit:
- Correlation of Ambulatory 24-Hour Esophageal pH Monitoring Results with Symptom Improvement in Patients with Noncardiac Chest Pain Due to Gastroesophageal Reflux DiseaseJournal of Clinical Gastroenterology, 1999
- Evaluation of omeprazole as a cost‐effective diagnostic test for gastro‐oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 1999
- One-Week Omeprazole Treatment in the Diagnosis of Gastro-oesophageal Reflux DiseaseScandinavian Journal of Gastroenterology, 1998
- Empiric therapy for gastroesophageal reflux diseaseArchives of internal medicine (1960), 1995
- Omeprazole for the treatment of posterior laryngitisThe American Journal of Medicine, 1994